- Home
- SYRE vs PACS Comparison
SYRE vs PACS Comparison
Compare SYRE & PACS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SYRE | PACS |
|---|---|---|
| Founded | 2013 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 7.7B |
| IPO Year | 2015 | 2024 |
Fundamental Metrics
Financial Performance| Metric | SYRE | PACS |
|---|---|---|
| Price | $90.96 | $42.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 4 |
| Target Price | ★ $85.08 | $45.50 |
| AVG Volume (30 Days) | ★ 1.1M | 640.2K |
| Earning Date | 05-08-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 221.05 |
| EPS | N/A | ★ 0.97 |
| Revenue | N/A | ★ $5,288,932,000.00 |
| Revenue This Year | N/A | $10.19 |
| Revenue Next Year | N/A | $8.58 |
| P/E Ratio | ★ N/A | $43.36 |
| Revenue Growth | N/A | ★ 29.32 |
| 52 Week Low | $14.51 | $10.31 |
| 52 Week High | $110.18 | $49.49 |
Technical Indicators
Market Signals| Indicator | SYRE | PACS |
|---|---|---|
| Relative Strength Index (RSI) | 43.19 | 41.62 |
| Support Level | $82.83 | $32.91 |
| Resistance Level | $92.10 | $42.35 |
| Average True Range (ATR) | 3.85 | 1.58 |
| MACD | 0.24 | -0.13 |
| Stochastic Oscillator | 56.93 | 14.61 |
Price Performance
Historical ComparisonAbout SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About PACS PACS Group Inc.
PACS Group Inc is a post-acute healthcare company mainly focused on delivering skilled nursing care through a portfolio of independently operated facilities. The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after getting discharged from the hospital. It also provides senior care, assisted living, and independent living options in some of the communities. The company has one reportable segment.